Search for: "Parkinson's Disease"
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical) Therapy
HSMN NewsFeed,
2 Nov 2009:
Devices, Endocrinology[Pico-Tesla Magnetic Therapies, Resonator, Magneceutical, diabetes]
Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
HSMN NewsFeed,
12 Oct 2009:
Biopharmaceuticals, Licensing[Novartis, Novartis Pharma AG, Vanda Pharmaceuticals, Fanapt, iloperidone]
Pico-Tesla Starts Phase III Clinical Trial of Its Proprietary Magnetic (Magneceutical) Therapy for Parkinson's Disease
HSMN NewsFeed,
5 Oct 2009:
Devices, Neurology[Pico-Tesla Magnetic Therapies, Resonator, Magneceutical, Parkinson’s disease]
Abbott to Acquire Solvay Pharmaceuticals Business
HSMN NewsFeed,
28 Sep 2009:
Biopharmaceuticals, Mergers & Acquisitions[Abbott, Solvay Pharmaceuticals]
St. Jude Medical Receives CE Mark Approval for World's Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson's Disease
HSMN NewsFeed,
9 Sep 2009:
Devices, Neurology, Regulatory[St. Jude Medical, Brio neurostimulator, deep brain stimulation, Parkinson’s]
Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors
HSMN NewsFeed,
3 Sep 2009:
Biopharmaceuticals, Neurology, Personnel[Satori Pharmaceuticals]
ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis
HSMN NewsFeed,
1 Sep 2009:
Biopharmaceuticals, Neurology[ACADIA Pharmaceuticals, Pimavanserin, Parkinson’s disease]
Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery
HSMN NewsFeed,
31 Aug 2009:
Devices, Neurosurgery[Integra LifeSciences, MAYFIELD Infinity XR2, Radiolucent Cranial Stabilization]
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
HSMN NewsFeed,
25 Aug 2009:
Biopharmaceuticals, Personnel[Adamas Pharmaceuticals]
Adamas Pharmaceuticals Raises $40 Million in Series D Financing
HSMN NewsFeed,
18 Aug 2009:
Biopharmaceuticals, Venture Capital, Personnel[Adamas Pharmaceuticals]
Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
HSMN NewsFeed,
5 Aug 2009:
Biopharmaceuticals, Neurology[Ceregene, CERE-120, Parkinson's disease]
Medtronic Files Pre-Market Approval Application for FDA Approval of Deep Brain Stimulation for Treatment-Resistant Epilepsy
HSMN NewsFeed,
16 Jul 2009:
Devices, Neurology, FDA[Medtronic, Deep Brain Stimulation, epilepsy, SANTE study]
St. Jude Medical Announces Australian TGA Regulatory Approval for Libra Deep Brain Stimulation Systems for Parkinson's Disease
HSMN NewsFeed,
14 Jul 2009:
Devices, Neurology, Regulatory[St. Jude Medical, deep brain stimulation, Parkinson’s disease, essential tremor]
A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients With Functional Brain Disorders
HSMN NewsFeed,
14 Jul 2009:
Devices, Neurosurgery[InSightec, Focused Ultrasound, neuropathic pain]
Clinical Data Presented at International Congress Showed Treatment With Neupro(R) (rotigotine) Significantly Improved Early Morning akinesia and was Generally Well Tolerated Over Four Years
HSMN NewsFeed,
12 Jun 2009:
Biopharmaceuticals, Neurology[UCB, rotigotine, Neupro , Parkinson's Disease]
St. Jude Medical Completes Implants in U.S. Study of Deep Brain Stimulation for Parkinson's Disease
HSMN NewsFeed,
8 Jun 2009:
Devices, Neurology[St. Jude Medical, deep brain stimulation, Libra , LibraXP, Parkinson’s disease]
UCB receives CHMP positive opinion on bringing Neupro(R) back to all patients in Europe
HSMN NewsFeed,
29 May 2009:
Biopharmaceuticals, Neurology, Regulatory[UCB, Neupro, rotigotine transdermal patch, Parkinson's disease]
Power3 Medical Announces Scientific Breakthrough for Its NuroPro(R) Blood Test; Diagnosis of Different Forms of Alzheimer's
HSMN NewsFeed,
28 May 2009:
Diagnostics, Neurology[Power3 Medical Products, NuroPro, Alzheimer's disease]
Power3 Medical Announces Better Than Expected Results for Early Stage Diagnosis Capability of the NuroPro(R) PD Test for Parkinson's Disease
HSMN NewsFeed,
18 May 2009:
Diagnostics, Neurology[Power3 Medical Products, NuroPro, Parkinson's disease]
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
HSMN NewsFeed,
18 May 2009:
Biopharmaceuticals, FDA[Janssen Pharmaceuticals, RISPERDAL, risperidone, Bipolar Disorder]
Study Shows Piclozotan Improves Both Dyskinesia and OFF Time in Parkinson's Disease Patients On Levodopa Therapy
HSMN NewsFeed,
14 May 2009:
Biopharmaceuticals, Neurology[Asubio Pharmaceuticals, Piclozotan, Parkinson's Disease]
Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting
HSMN NewsFeed,
11 May 2009:
Diagnostics, Neurology[Transgenomic, Power3 Medical Products, NuroPro , Alzheimer's, Parkinson's]
Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer Pain
HSMN NewsFeed,
8 May 2009:
Biopharmaceuticals, Drug Delivery, Oncology[Archimedes Pharma, NasalFent, fentanyl, breakthrough cancer pain]
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease
HSMN NewsFeed,
7 May 2009:
Biopharmaceuticals, Neurology[Merck Serono, Merck KGaA, Newron Pharmaceuticals, safinamide, SETTLE study]
Teva Announces Extension of Patent Protection for Azilect
HSMN NewsFeed,
6 May 2009:
Biopharmaceuticals, Neurology, Generics[Teva Pharmaceutical, Azilect, Parkinson's disease]
Accera, Inc. Launches Neuera Pharmaceuticals, Inc.
HSMN NewsFeed,
15 Apr 2009:
Biopharmaceuticals, Neurology, Venture Capital[Accera, Neuera Pharmaceuticals]
New Keppra XR(TM) Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures
HSMN NewsFeed,
10 Apr 2009:
Biopharmaceuticals, Neurology[UCB, Keppra XR, levetiracetam, epilepsy]
Neuraltus Pharmaceuticals Raises $17 Million Series A Funding
HSMN NewsFeed,
26 Mar 2009:
Biopharmaceuticals, Neurology, Venture Capital[Neuraltus Pharmaceuticals, Amyotropic Lateral Sclerosis, Parkinson's Disease]
Power3 Medical 'On-Track and On-Plan' to Commercialize Diagnostic Blood Tests
HSMN NewsFeed,
18 Mar 2009:
Diagnostics, Neurology[Power3 Medical Products, NuroPro, BC-SeraPro, Alzheimer’s, Parkinson’s disease]
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
HSMN NewsFeed,
3 Feb 2009:
Biopharmaceuticals, Neurology[Merck Serono, Merck KGaA, Newron, Safinamide, Parkinson's Disease]
St. Jude Medical Announces European CE Mark Approval for Libra Deep Brain Stimulation Systems for Parkinson's Disease
HSMN NewsFeed,
26 Jan 2009:
Devices, Neurology, Regulatory[St. Jude Medical, Libra , LibraXP, deep brain stimulation]
GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome
HSMN NewsFeed,
9 Jan 2009:
Biopharmaceuticals, Neurology, FDA[GlaxoSmithKline, XenoPort, Solzira, gabapentin, Restless Legs Syndrome]
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
HSMN NewsFeed,
8 Jan 2009:
Biopharmaceuticals, Neurology, Venture Capital, Personnel[Satori Pharmaceuticals, Alzheimer's disease, Parkinson's disease]
Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
HSMN NewsFeed,
12 Nov 2008:
Devices, Neurology, Venture Capital[Intelect Medical, Boston Scientific, Greatbatch, neuromodulation]
GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
HSMN NewsFeed,
21 Oct 2008:
Biopharmaceuticals, Acquisitions[GlaxoSmithKline, Laclede, Biotene]
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT
HSMN NewsFeed,
22 Sep 2008:
Biopharmaceuticals, Generics, FDA[Mylan, Carbidopa, Levodopa, Schwarz Pharma, Parcopa, Parkinson's disease]
Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
HSMN NewsFeed,
21 Sep 2008:
Devices[Coapt Systems, Novielle Voice Gel]
The European Commission Grants Orphan Drug Designation to Alseres Pharmaceuticals' Spinal Cord Injury Treatment, Cethrin(R)
HSMN NewsFeed,
18 Sep 2008:
Biopharmaceuticals, Neurology, Regulatory[Alseres Pharmaceuticals, Cethrin, orphan drug designation]
GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome
HSMN NewsFeed,
16 Sep 2008:
Biopharmaceuticals[GlaxoSmithKline, XenoPort, Solzira, gabapentin enacarbil, Restless Legs Syndrome]
Keppra XR(TM) Approved in the U.S.
HSMN NewsFeed,
15 Sep 2008:
Biopharmaceuticals, Neurology, FDA[UCB, Keppra XR, levetiracetam, epilepsy]
Power3 Medical Products, Inc. Appoints Helen Park as Interim Chief Executive Officer
HSMN NewsFeed,
12 Sep 2008:
Diagnostics, Personnel[Power3 Medical Products]
ADAGIO Trial Results Show Teva's AZILECT(R) 1 mg Tablets Slow Progression of Parkinson's Disease
HSMN NewsFeed,
26 Aug 2008:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, ADAGIO trial, Parkinson's disease, AZILECT, rasagiline]
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
HSMN NewsFeed,
5 Aug 2008:
Biopharmaceuticals, Personnel[Marinus Pharmaceuticals]
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs
HSMN NewsFeed,
5 Aug 2008:
Biopharmaceuticals, Personnel[Panacea Pharmaceuticals]
Medtronic Launches First Insertable Cardiac Monitor in Japan
HSMN NewsFeed,
15 Jul 2008:
Devices, Cardiology, Monitoring, Regulatory[Medtronic, Reveal DX, Insertable Cardiac Monitor, syncope]
U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease
HSMN NewsFeed,
13 Jun 2008:
Biopharmaceuticals, Neurology, FDA[GlaxoSmithKline, Requip XL, ropinirole, Parkinson's disease]
New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)
HSMN NewsFeed,
10 Jun 2008:
Biopharmaceuticals[Boehringer Ingelheim, pramipexole, Mirapexin, Sifrol, Restless Legs Syndrome]
Osmotica Pharmaceutical Receives FDA Approval to Market Novel Forms of Extended Release Venlafaxine HCl
HSMN NewsFeed,
23 May 2008:
Biopharmaceuticals, FDA[Osmotica Pharmaceutical, Venlafaxine, Effexor XR, Wyeth]
Myriad Genetics Selects Lundbeck as European Partner for Flurizan
HSMN NewsFeed,
22 May 2008:
Biopharmaceuticals, Neurology[Myriad Genetics, Lundbeck, Flurizan, Alzheimer's disease]
Neupro(R) recommended for approval in Europe for Restless Legs Syndrome
HSMN NewsFeed,
25 Apr 2008:
Biopharmaceuticals, Regulatory[UCB, Neupro, rotigotine transdermal patch, Restless Legs Syndrome]
Ceregene Announces Two Key Additions to Leadership Team
HSMN NewsFeed,
23 Apr 2008:
Biopharmaceuticals, Personnel[Ceregene]
Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
HSMN NewsFeed,
17 Apr 2008:
Biopharmaceuticals, Diagnostics, Neurology[Alseres Pharmaceuticals, ALTROPANE, Parkinson's Disease, Essential Tremor]
New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance for People With Restless Legs Syndrome (RLS)
HSMN NewsFeed,
17 Apr 2008:
Biopharmaceuticals[Boehringer Ingelheim, pramipexole, Mirapexin, Sifrol, Restless Legs Syndrome]
Medtronic Activa(R) Deep Brain Stimulation Patient Referral Advisor Software Launched in United States
HSMN NewsFeed,
16 Apr 2008:
Devices, Neurology[Medtronic, Activa DBS, Patient Referral Advisor, Parkinson’s disease]
Vasogen Announces Implementation of Strategic Restructuring Plan
HSMN NewsFeed,
14 Apr 2008:
Biopharmaceuticals[Vasogen, Celacade]
Stem Cells From Menstrual Blood Show Therapeutic Potential
HSMN NewsFeed,
14 Apr 2008:
Regenerative Medicine[Cryo-Cell International, Menstrual stem cells, stem cell]
Status of the E2007 (perampanel) Development Program - Termination of Parkinson's Disease Clinical Development and Focus on Neuropathic Pain and Epilepsy Indications
HSMN NewsFeed,
11 Apr 2008:
Biopharmaceuticals[Eisai, E2007, perampanel, AMPA receptor]
ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis
HSMN NewsFeed,
31 Mar 2008:
Biopharmaceuticals[ACADIA Pharmaceuticals, pimavanserin, Parkinson’s disease]
UCB advises US-physicians to down-titrate patients on Neupro(R) in view of out-of-stock situation in the US
HSMN NewsFeed,
20 Mar 2008:
Biopharmaceuticals, Neurology, Product Recall[UCB, Neupro , rotigotine, rotigotine transdermal system, Parkinson's disease]
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
HSMN NewsFeed,
27 Feb 2008:
Biopharmaceuticals, Neurology, FDA[Kyowa Hakko Kogyo, Kyowa Pharmaceutical, istradefylline, KW-6002, Parkinson's]
Integra LifeSciences Introduces Titanium Skull Pins for Intra-Operative Brain Surgery
HSMN NewsFeed,
27 Feb 2008:
Devices, Neurosurgery[Integra LifeSciences, MAYFIELD, skull pins]
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
HSMN NewsFeed,
19 Feb 2008:
Biopharmaceuticals, Generics, FDA[Barr Pharmaceuticals, Barr Laboratories, Boehringer Ingelheim, Mirapex]
Solvay Pharmaceuticals, Inc. Receives Fast Track Designation From U.S. Food and Drug Administration for Levodopa/Carbidopa Intestinal Gel for Advanced Parkinson's Disease
HSMN NewsFeed,
18 Feb 2008:
Biopharmaceuticals, FDA, Neurology[Solvay Pharmaceuticals, levodopa/carbidopa, intestinal gel, Parkinson's disease]
Chelsea Therapeutics Begins Patient Dosing in Pivotal Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension
HSMN NewsFeed,
7 Feb 2008:
Biopharmaceuticals[Chelsea Therapeutics, Droxidopa, orthostatic hypotension]
Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
HSMN NewsFeed,
23 Jan 2008:
Diagnostics, Personnel[Molecular Biometrics, metabolomics]
Amarin Announces Management Changes Including Appointment of New CEO
HSMN NewsFeed,
19 Dec 2007:
Biopharmaceuticals, Personnel[Amarin Corp]
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
HSMN NewsFeed,
13 Dec 2007:
Biopharmaceuticals, Neurology, FDA[Neurologix, Parkinson’s disease, Neurologix gene transfer, gene therapy]
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
HSMN NewsFeed,
13 Dec 2007:
Biopharmaceuticals, Neurology[UCB, Neupro, Rotigotine, Parkinson's disease]
Neupro(R) Filed with the FDA for the Treatment of Restless Legs Syndrome
HSMN NewsFeed,
13 Dec 2007:
Biopharmaceuticals, Neurology[UCB, Neupro, rotigotine, restless legs syndrome]
Ceregene Promotes Dr. Raymond Bartus to Executive Vice President
HSMN NewsFeed,
6 Dec 2007:
Biopharmaceuticals, Personnel[Ceregene]
Amarin Signs Agreement to Acquire Ester Neurosciences
HSMN NewsFeed,
5 Dec 2007:
Biopharmaceuticals, Neurology, Mergers & Acquisitions[Amarin Corp, Ester Neurosciences]
Neupro(R) Filed in Europe for the Treatment of Restless Legs Syndrome
HSMN NewsFeed,
5 Dec 2007:
Biopharmaceuticals, Regulatory[UCB, Neupro , rotigotine transdermal patch, Restless Legs Syndrome]
Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials
HSMN NewsFeed,
20 Nov 2007:
Regenerative Medicine, Neurology, Licensing[Neuralstem, stem cell]
Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program
HSMN NewsFeed,
19 Nov 2007:
Biopharmaceuticals, Neurology[Amarin Corp, Miraxion, Huntington's disease, TREND-HD trial]
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
HSMN NewsFeed,
12 Nov 2007:
Biopharmaceuticals, FDA[Chelsea Therapeutics, Droxidopa, orthostatic hypotension]
BrainStorm Cell Therapeutics Secures Significant Equity Financing and Raises Research Budget
HSMN NewsFeed,
12 Nov 2007:
Regenerative Medicine, Neurology[BrainStorm Cell Therapeutics, stem cell]
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer
HSMN NewsFeed,
1 Nov 2007:
Biopharmaceuticals, Personnel[Acologix]
Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg
HSMN NewsFeed,
30 Oct 2007:
Biopharmaceuticals, Generics, FDA[Barr Pharmaceuticals, Barr Laboratories, Boehringer Ingelheim, Mirapex]
Neurogen Corporation Announces Appointment of Kenneth J. Sprenger to Vice President, Clinical Development and Operations
HSMN NewsFeed,
17 Oct 2007:
Biopharmaceuticals, Personnel[Neurogen]
Cortex Names Pierre V. Tran, MD, MMM, Chief Medical Officer and Vice President of Clinical Development
HSMN NewsFeed,
16 Oct 2007:
Biopharmaceuticals, Neurology, Personnel[Cortex Pharmaceuticals]
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
HSMN NewsFeed,
10 Oct 2007:
Biopharmaceuticals, Neurology, Personnel[Accera, Ketasyn, Alzheimer's disease]
Amarin Announces Initiation of Cardiovascular Development Strategy
HSMN NewsFeed,
10 Oct 2007:
Biopharmaceuticals[Amarin , dyslipidemia, metabolic syndrome]
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
HSMN NewsFeed,
10 Oct 2007:
Biopharmaceuticals, Personnel[NuPathe]
BrainStorm on the Verge of a Breakthrough Towards Developing a Cure for Lou Gehrig's Disease
HSMN NewsFeed,
8 Oct 2007:
Regenerative Medicine, Neurology[BrainStorm Cell Therapeutics, Amyelotrophic Lateral Sclerosis, stem cell]
AVANIR Granted Special Protocol Assessment (SPA) From FDA for Confirmatory Phase III Trial of Zenvia in Patients With PBA
HSMN NewsFeed,
8 Oct 2007:
Biopharmaceuticals, Neurology[AVANIR Pharmaceuticals, Zenvia, dextromethorphan, quinidine, pseudobulbar affect]
Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
HSMN NewsFeed,
8 Oct 2007:
Biopharmaceuticals, Neurology, Drug Delivery[UCB, rotigotine, restless legs syndrome]
Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinson's Disease
HSMN NewsFeed,
8 Oct 2007:
Biopharmaceuticals, Neurology, Drug Delivery[UCB, Neupro, Rotigotine, dopamine agonist patch, Parkinson's disease]
Santhera Announces Start of US Phase III Clinical Trial with SNT-MC17 in Friedreich's Ataxia and Provides Details on Study Design
HSMN NewsFeed,
28 Sep 2007:
Biopharmaceuticals, Neurology, FDA[Santhera Pharmaceuticals, SNT-MC17, idebenone, Friedreich's Ataxia, Ataxia]
EnVivo Pharmaceuticals Announces Executive Appointment
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Personnel[EnVivo Pharmaceuticals]
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Personnel[Titan Pharmaceuticals]
Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
HSMN NewsFeed,
24 Sep 2007:
Biopharmaceuticals, Neurology[Alseres Pharmaceuticals, spinal cord injury, Cethrin]
Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc.
HSMN NewsFeed,
19 Sep 2007:
Regenerative Medicine, Neurology, Litigation[Neuralstem, StemCells, stem cell]
Valeant Pharmaceuticals Announces the Launch of the zelaCARD for Parkinson's Disease Patients Taking Zelapar(R)
HSMN NewsFeed,
18 Sep 2007:
Biopharmaceuticals, Neurology[Valeant Pharmaceuticals, Zelapar, zelaCARD, Parkinson's disease]
Neurogen Corporation Announces Appointment of Stephen R. Davis as President
HSMN NewsFeed,
14 Sep 2007:
Biopharmaceuticals, Personnel[Neurogen]
BrainStorm Cell Therapeutics Takes Initial Steps Toward FDA Submission
HSMN NewsFeed,
10 Sep 2007:
Regenerative Medicine, Neurology[BrainStorm Cell Therapeutics, stem cell, Parkinson's Disease]
Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
HSMN NewsFeed,
30 Aug 2007:
Biopharmaceuticals, Personnel[Prestwick Pharmaceuticals]
Neurogen Corporation Announces Appointment of George D. Maynard to Vice President
HSMN NewsFeed,
30 Aug 2007:
Biopharmaceuticals, Personnel[Neurogen]
Prestwick Pharmaceuticals, Inc. Strengthens Management Team with Appointment of Robert S. Radie as Chief Business Officer
HSMN NewsFeed,
23 Aug 2007:
Biopharmaceuticals, Personnel[Prestwick Pharmaceuticals]
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
HSMN NewsFeed,
16 Aug 2007:
Biopharmaceuticals, Neurology, Regulatory[Santhera Pharmaceuticals, Takeda Pharmaceutical, idebenone, SNT-MC17, Ataxia]
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
HSMN NewsFeed,
14 Aug 2007:
Biopharmaceuticals, Regulatory[Chelsea Therapeutics, Droxidopa, orthostatic hypotension]
Stem Cell Therapy International Acquires Exclusive Worldwide Rights to New, Anti-Rejection Stem Cell Technology
HSMN NewsFeed,
2 Aug 2007:
Regenerative Medicine[Stem Cell Therapy International, stem cell]
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
HSMN NewsFeed,
31 Jul 2007:
Biopharmaceuticals, Acquisitions, Neurology[Neuren Pharmaceuticals, Motiva , Hamilton Pharmaceuticals]
Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases
HSMN NewsFeed,
30 Jul 2007:
Biopharmaceuticals, Devices, Drug Delivery, Neurology[Alnylam Pharmaceuticals, Medtronic, RNA Interference, Huntington's disease]
NeuroDerm Raises $2.5 Million in Series A Financing
HSMN NewsFeed,
23 Jul 2007:
Biopharmaceuticals, Venture Capital[NeuroDerm]
Panacea Pharmaceuticals Announces the Availability of LC Detect(sm), a Serum-Based Diagnostic Test for Lung Cancer
HSMN NewsFeed,
17 Jul 2007:
Diagnostics, Oncology[Panacea Pharmaceuticals, LC Detect, lung cancer]
UCB Announces the U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
HSMN NewsFeed,
16 Jul 2007:
Biopharmaceuticals, Neurology[UCB, SCHWARZ PHARMA, Neupro , Rotigotine, Parkinson's disease]
BrainStorm Cell Therapeutics Elects Moshe Lion to Its Board of Directors
HSMN NewsFeed,
16 Jul 2007:
Regenerative Medicine, Personnel[BrainStorm Cell Therapeutics, stem cell]
SCHWARZ PHARMA and UCB, Inc. Announce U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
HSMN NewsFeed,
16 Jul 2007:
Biopharmaceuticals, Neurology[SCHWARZ PHARMA, UCB, Rotigotine, Transdermal System, Neupro, Parkinson's disease]
Avicena to Advance Huntington's Disease Clinical Program into Phase III
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals, Neurology[Avicena Group, HD-02, Huntington's Disease]
Titan Annnounces Completion of Patient Enrollment in Randomized Phase IIb Clinical Study of Spheramine(R) In Parkinson's Disease
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals, Neurology[Titan Pharmaceuticals, Spheramine, Parkinson's disease]
Alseres Pharmaceuticals Announces FDA Clearance to Increase Dose Level in Cethrin(R) Phase I/IIa Clinical Trial for Acute Spinal Cord Injury at U.S. Sites
HSMN NewsFeed,
27 Jun 2007:
Biopharmaceuticals, Neurology, FDA[Alseres Pharmaceuticals, Boston Life Sciences, Cethrin, spinal cord injury]
Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease
HSMN NewsFeed,
21 Jun 2007:
Biopharmaceuticals, Neurology[Neurologix, Parkinson's disease, gene therapy]
Ceregene and Genzyme Announce Partnership for the Development and Commercialization of Cere-120 for Parkinson's Disease
HSMN NewsFeed,
21 Jun 2007:
Biopharmaceuticals, Neurology[Genzyme, Ceregene, CERE-120, Parkinson's disease]
Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Radiology[Avid Radiopharmaceuticals, Bayer Schering Pharma, 18F-AV1/ZK, imaging]
Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Neurology[Memory Pharmaceuticals, MEM 3454, Schizophrenia]
Gene Logic Collaboration Reveals Genomic Predictors of Parkinson's Disease
HSMN NewsFeed,
18 Jun 2007:
Diagnostics, Biopharmaceuticals, Neurology[Gene Logic, Parkinson's disease]
Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
HSMN NewsFeed,
18 Jun 2007:
Biopharmaceuticals, FDA[Cephalon, NUVIGIL, armodafinil]
Washington Hospital Healthcare System First in the United States to Treat Patients Using the New Leksell(R) Gamma Knife Perfexion(TM)
HSMN NewsFeed,
12 Jun 2007:
Devices, Oncology, Neurosurgery[Elekta, Leksell, Gamma Knife Perfexion, radiosurgery]
Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch
HSMN NewsFeed,
11 Jun 2007:
Devices, Neurology, Venture Capital[Intelect Medical, neuromodulation]
Boston Life Sciences, Inc. Changes Name to Alseres Pharmaceuticals, Inc.
HSMN NewsFeed,
8 Jun 2007:
Biopharmaceuticals[Boston Life Sciences, Alseres Pharmaceuticals]
International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of Parkinson's Disease
HSMN NewsFeed,
8 Jun 2007:
Biopharmaceuticals, Neurology[Teva Neuroscience, Parkinson's disease, AZILECT, rasagiline]
In 2009 Exonhit Aims to ask for Market Clearance in Europe for a Blood Diagnostic Test for Alzheimer's Disease
HSMN NewsFeed,
7 Jun 2007:
Diagnostics, Neurology[ExonHit Therapeutics, Alzheimer's disease]
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
HSMN NewsFeed,
3 Jun 2007:
Biopharmaceuticals, Oncology[sanofi-aventis, Oxford BioMedica , TroVax, renal cell carcinoma]
Panacea Pharmaceuticals Announces the Availability of PC Detect(sm) for Prostate Cancer Screening
HSMN NewsFeed,
31 May 2007:
Diagnostics, Oncology[Panacea Pharmaceuticals, Panacea Laboratories, PC Detect, prostate cancer]
Neuralstem's Cells Restore Motor Function in Spinal Ischemia-Paralyzed Rats
HSMN NewsFeed,
30 May 2007:
Regenerative Medicine[Neuralstem, stem cell]
Neuro-Hitech, Inc., Obtains Exclusive License to Combination Drugs for the Treatment of Alzheimer's Disease and Other Serious Neurological Disorders
HSMN NewsFeed,
30 May 2007:
Biopharmaceuticals, Neurology, Licensing[Neuro-Hitech, Huperzine, Alzheimer's disease, Parkinson's disease]
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
HSMN NewsFeed,
29 May 2007:
Biopharmaceuticals, Personnel[Boston Life Sciences]
New Agreement Boosts Pipeline for Synosia Therapeutics
HSMN NewsFeed,
22 May 2007:
Biopharmaceuticals, Licensing[Synosia Therapeutics, Syngenta]
CVRx(R), Inc. Appoints Todd Langevin Senior Vice President of Clinical and Commercial Development
HSMN NewsFeed,
17 May 2007:
Devices, Personnel[CVRx, Rheos, Baroreflex Hypertension Therapy]
NeuroVista Raises $33.8 Million in Series B Financing
HSMN NewsFeed,
10 May 2007:
Devices, Neurology, Venture Capital[NeuroVista, BioNeuronics, epilepsy]
FDA Approves SCHWARZ PHARMA's Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
HSMN NewsFeed,
10 May 2007:
Biopharmaceuticals, Drug Delivery, Neurology, FDA[SCHWARZ PHARMA, Neupro, Rotigotine Transdermal System, Parkinson's disease]
Avid Radiopharmaceuticals Closes $26 Million Series C Financing
HSMN NewsFeed,
9 May 2007:
Biopharmaceuticals, Radiology, Neurology, Venture Capital[Avid Radiopharmaceuticals]
Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
HSMN NewsFeed,
8 May 2007:
Biopharmaceuticals, Neurology[Vernalis, Biogen Idec, BIIB014, V2006, Parkinson's disease,]
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
HSMN NewsFeed,
2 May 2007:
Biopharmaceuticals, Neurology[Ceregene, CERE-110, Alzheimer's disease]
Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
HSMN NewsFeed,
2 May 2007:
Biopharmaceuticals[Neurogen, NGD-4715, MCHR1, obesity]
CleveMed Receives FDA Clearance to Market Wireless Movement Disorder Monitor
HSMN NewsFeed,
1 May 2007:
Devices, Neurology, Monitoring[CleveMed, Kinesia, ParkinSense]
Washington Hospital Installs First Leksell Gamma Knife(R) Perfexion(TM) in United States
HSMN NewsFeed,
30 Apr 2007:
Devices, Neurosurgery, Oncology[Elekta, Gamma Knife, Perfexion]
Meda Acquires Product Portfolio from the US Pharma Company Wyeth
HSMN NewsFeed,
27 Apr 2007:
Biopharmaceuticals, Acquisitions[Meda AB, Wyeth]
Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
HSMN NewsFeed,
24 Apr 2007:
Biopharmaceuticals, Neurology[Amarin Corp, Miraxion, Huntington's Disease]
William C. Oldaker and Scott V. Ogilvie Join Neuralstem Board of Directors
HSMN NewsFeed,
24 Apr 2007:
Regenerative Medicine, Neurology, Personnel[Neuralstem, stem cell]
Power3 Medical Able to Offer Blood-Based Tests for Detection of Breast Cancer and Neurodegenerative Diseases after Receiving CLIA High-Complexity Certification
HSMN NewsFeed,
19 Apr 2007:
Diagnostics, Personnel[Power3 Medical Products]
Integra LifeSciences Releases New Brain Mapping Software to Treat Parkinson's Disease
HSMN NewsFeed,
17 Apr 2007:
Devices, Neurology[Integra LifeSciences, Radionics, NeuroSight Arc, Parkinson's Disease]
SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology
HSMN NewsFeed,
16 Apr 2007:
Biopharmaceuticals, Neurology[SCHWARZ PHARMA, Rotigotine, PREFER Study, Parkinson's disease]
Boston Life Sciences, Inc. Announces Presentation of Cethrin(R) Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
HSMN NewsFeed,
16 Apr 2007:
Biopharmaceuticals, Neurology[Boston Life Sciences, Cethrin, nerve repair therapy, Rho Inhibitor]
Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer
HSMN NewsFeed,
16 Apr 2007:
Biopharmaceuticals, Personnel[Boston Life Sciences]
Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
HSMN NewsFeed,
13 Apr 2007:
Biopharmaceuticals, Neurology[Ceregene, CERE-120, Parkinson's disease]
Medtronic Wins Medical Design Excellence Awards for Products Related to Activa(R) Deep Brain Stimulation Therapy and Ear, Nose and Throat Surgery
HSMN NewsFeed,
12 Apr 2007:
Devices[Medtronic, Activa , Deep Brain Stimulation, Nexframe, Stimloc, LandmarX]
Amarin Appoints Declan Doogan to New Position of President-Research and Development
HSMN NewsFeed,
10 Apr 2007:
Biopharmaceuticals, Personnel[Amarin Corp]
John Conron Joins Neuralstem as Chief Financial Officer
HSMN NewsFeed,
10 Apr 2007:
Regenerative Medicine, Neurology, Personnel[Neuralstem, stem cell]
Exciting Developments on the Horizon for Parkinson Disease, Says Medical Director for the National Parkinson Foundation
HSMN NewsFeed,
6 Apr 2007:
Biopharmaceuticals, Regenerative Medicine, Neurology[Parkinson disease, Parkinson's disease]
One of the Largest-Ever Parkinson's Disease Studies Initiated Across the United States
HSMN NewsFeed,
5 Apr 2007:
Biopharmaceuticals, Neurology[Avicena Group, Parkinson's disease, PD-02, NET-PD]
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
HSMN NewsFeed,
3 Apr 2007:
Biopharmaceuticals, Personnel[Amarin Corp]
Once Daily, Extended-Release Ropinirole Improves Parkinson's Symptoms in Patients not Optimally Controlled With Levodopa
HSMN NewsFeed,
2 Apr 2007:
Biopharmaceuticals, Neurology[GlaxoSmithKline, REQUIP, ropinirole, Parkinson Disease]
Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application
HSMN NewsFeed,
30 Mar 2007:
Biopharmaceuticals, FDA[Cephalon, NUVIGIL, armodafinil]
Dr. Robert Langer Named as Chairman of Boston Life Sciences, Inc. Newly Formed Science and Technology Committee of the Board of Directors
HSMN NewsFeed,
22 Mar 2007:
Devices, Personnel[Boston Life Sciences]
Avicena Announces Patient Enrollment in National Institutes of Health (NIH) Phase III Parkinson's Disease Trial
HSMN NewsFeed,
22 Mar 2007:
Biopharmaceuticals, Neurology[Avicena Group, PD-02, Parkinson's disease, creatine]
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
HSMN NewsFeed,
19 Mar 2007:
Biopharmaceuticals, Radiology, Neurology[Avid Radiopharmaceuticals, AV-1, Alzheimer's disease, ß-amyloid, imaging]
Medivation Announces Presentation of Full Top-Line Data From Dimebon(TM) Six-Month Trial at Major International Alzheimer's Disease Conference
HSMN NewsFeed,
19 Mar 2007:
Biopharmaceuticals, Neurology[Medivation, Dimebon, Alzheimer's disease]
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
HSMN NewsFeed,
19 Mar 2007:
Biopharmaceuticals, Drug Delivery[Vyteris, LidoSite]
Neuralstem Inc. Raises $5 Million in a Private Placement
HSMN NewsFeed,
16 Mar 2007:
Regenerative Medicine, Neurology[Neuralstem]
Amarin Expands Neurology Pipeline With Epilepsy Product Candidate
HSMN NewsFeed,
6 Mar 2007:
Biopharmaceuticals, Drug Delivery, Neurology, Licensing[Amarin Corp, Lorazepam, NanoCrystal, Elan Corp, Epilepsy]
Amarin Appoints Professor William Hall as Non-Executive Director
HSMN NewsFeed,
27 Feb 2007:
Biopharmaceuticals, Neurology, Personnel[Amarin Corp]
Cardiome Announces Management Appointments
HSMN NewsFeed,
22 Feb 2007:
Biopharmaceuticals, Cardiology, Personnel[Cardiome Pharma]
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
HSMN NewsFeed,
22 Feb 2007:
Biopharmaceuticals, Regenerative Medicine, Personnel[VistaGen Therapeutics, stem cell]
Vyteris Announces Senior Staff Promotions
HSMN NewsFeed,
20 Feb 2007:
Devices, Drug Delivery, Personnel[Vyteris]
Amarin Announces Completion of Two Phase III Trials With Miraxion in Huntington's Disease
HSMN NewsFeed,
5 Feb 2007:
Biopharmaceuticals, Neurology[Amarin Corp, Miraxion, ethyl-EPA, Huntington's Disease]
Proneuron Announces the Receipt of a $430,000 Grant from the Michael J. Fox Foundation to Develop Its PN277 for the Treatment of Parkinson's Disease
HSMN NewsFeed,
24 Jan 2007:
Biopharmaceuticals, Neurology[Proneuron Biotechnologies, Parkinson's disease]
Amicus Therapeutics Receives Grant From Michael J. Fox Foundation for Parkinson's Research
HSMN NewsFeed,
23 Jan 2007:
Biopharmaceuticals, Neurology[Amicus Therapeutics, pharmacological chaperone, Parkinson's disease]
Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative Diseases
HSMN NewsFeed,
19 Jan 2007:
Biopharmaceuticals, Radiology, Licensing[Bayer Schering Pharma, Taisho Pharmaceutical, Nihon Nohyaku, imaging]
Neuralstem Licenses Out Compounds for Diabetes Treatment
HSMN NewsFeed,
11 Jan 2007:
Regenerative Medicine, Licensing[Neuralstem, neural stem cells]
Panacea Pharmaceuticals Appoints Pamela Harris, MD, Vice President Medical and Clinical Affairs
HSMN NewsFeed,
10 Jan 2007:
Biopharmaceuticals, Personnel[Panacea Pharmaceuticals]
Boston Life Sciences Acquires Rights to Develop and Commercialize Promising Phase II Spinal Cord Injury Drug, Cethrin(R), in Exclusive Worldwide License
HSMN NewsFeed,
4 Jan 2007:
Biopharmaceuticals, Neurology, Licensing[Boston Life Sciences, BioAxone Therapeutic, Cethrin, acute spinal cord injury]
SCHWARZ PHARMA Announces Publication of Rotigotine Data in Neurology
HSMN NewsFeed,
3 Jan 2007:
Biopharmaceuticals, Drug Delivery, Neurology[SCHWARZ PHARMA, rotigotine, Parkinson's disease]
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
HSMN NewsFeed,
22 Dec 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, Parkinson's disease, ADAGIO study, AZILECT, rasagiline]
Avicena Signs Agreement with the National Institute of Neurological Disorders and Stroke for Phase III Trial for Novel Parkinson's Disease Candidate
HSMN NewsFeed,
6 Dec 2006:
Biopharmaceuticals, Neurology[Avicena Group, PD-02, Parkinson's disease]
Stem Cell Therapy International Reports the Successful Treatment of a Stroke Patient With Their Proprietary Stem Cell Transplantation Therapy
HSMN NewsFeed,
29 Nov 2006:
Regenerative Medicine, Neurology[Stem Cell Therapy International, stem cell, stroke]
Neurogen In-licenses Drug Candidate for Parkinson's Disease and Restless Legs Syndrome
HSMN NewsFeed,
28 Nov 2006:
Biopharmacetuicals, Licensing[Neurogen , Wyeth, Aplindore, Parkinson's disease, restless legs syndrome]
Neuro-Hitech Announces Agreement to Acquire Q-RNA, Inc.
HSMN NewsFeed,
17 Nov 2006:
Biopharmaceuticals, Neurology, Mergers & Acquisitions[Neuro-Hitech, Q-RNA Inc]
FDA Approves MIRAPEX for the Treatment of Moderate-to-Severe Primary Restless Legs Syndrome
HSMN NewsFeed,
10 Nov 2006:
Biopharmaceuticals, FDA[Boehringer Ingelheim, MIRAPEX, pramipexole, Restless Legs Syndrome]
Raptor Pharmaceuticals Corp. Announces an Exclusive Worldwide License Agreement for Mesd Reagents for Treatment of Cancer and Osteoporosis
HSMN NewsFeed,
6 Nov 2006:
Biopharmaceuticals, Licensing[Raptor Pharmaceutical, Mesd reagent]
Gladstone Institutes and Merck & Co., Inc. Announce Major Research Collaboration and Exclusive License Agreement in Field of Apolipoprotein (Apo) E
HSMN NewsFeed,
2 Nov 2006:
Biopharmaceuticals, Neurology, Licensing[Merck, Apolipoprotein, Alzheimer's Disease]
Boehringer Ingelheim Launches PROUD Study to Explore Possible Disease-Modifying Effect of Pramipexole
HSMN NewsFeed,
31 Oct 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim, pramipexole, Parkinson's disease]
Stem Cell Treatment Proven to Reduce Parkinson's Symptoms
HSMN NewsFeed,
24 Oct 2006:
Regenerative Medicine, Neurology[Retinal Pigment Epithelial cells, stem cell, Parkinson's disease]
Serono and Newron Announce Global Development and Commercialization Agreement for Safinamide
HSMN NewsFeed,
16 Oct 2006:
Biopharmaceuticals, Neurology, Licensing[Serono, Newron Pharmaceuticals, safinamide, Parkinson's disease]
Osta Announces Promising Clinical Results on Blood Tests for Parkinson's Disease & Alzheimer's Disease
HSMN NewsFeed,
11 Oct 2006:
Diagnostics, Neurology[Osta Biotechnologies, Parkinson's disease, Alzheimer's disease]
New Data for FTY720 -- Aiming to Become the First Orally Effective Multiple Sclerosis Treatment -- Show Sustained Benefits Over Two Years
HSMN NewsFeed,
28 Sep 2006:
Biopharmaceuticals, Neurology[Novartis, FTY720, fingolimod, multiple sclerosis]
Boston Life Sciences, Inc. Announces Findings from Review of POET-1 Study of ALTROPANE(R) Molecular Imaging Agent
HSMN NewsFeed,
25 Sep 2006:
Biopharmaceuticals, Radiology, Neurology[Boston Life Sciences, ALTROPANE, Imaging Agent, Parkinson's Disease]
Panacea Pharmaceuticals Announces Appointments of Christine L. Brauer, Ph.D. as Vice President, Regulatory Affairs; and Jefferey Jones, M.S., as Director of Quality
HSMN NewsFeed,
21 Sep 2006:
Biopharmaceuticals, Personnel[Panacea Pharmaceuticals]
NuPathe Closes $15 Million Financing
HSMN NewsFeed,
13 Sep 2006:
Biopharmaceuticals, Venture Capital[NuPathe]
Omeros Acquires Nura
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Mergers & Acquisitions[Omeros , Nura Inc]
SCHWARZ PHARMA's Parkinson Patch Offers Additional Benefits
HSMN NewsFeed,
5 Sep 2006:
Biopharmaceuticals, Drug Delivery, Neurology[Schwarz Pharma, Neupro, rotigotine transdermal patch, Parkinson's disease]
New Study Reveals Investigational 24-Hour Formulation of Requip(R) (ropinirole HCl) Tablets Reduced "Off" Time for Patients With Parkinson's Disease
HSMN NewsFeed,
4 Sep 2006:
Biopharmaceuticals, Neurology[GlaxoSmithKline, Requip, ropinirole, Parkinson's Disease]
New England Journal of Medicine Reports Superior Benefits of Deep Brain Stimulation for Advanced Parkinson's Disease
HSMN NewsFeed,
30 Aug 2006:
Devices, Neurology[Medtronic, Activa , Deep Brain Stimulation, Parkinson's disease]
Pramipexole Safe and Effective in Treating Restless Legs Syndrome, Study Shows
HSMN NewsFeed,
24 Aug 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim, pramipexole, restless legs syndrome]
New Study of Depressive Symptoms in Parkinson's Disease Patients Shows Positive Results for Mirapex
HSMN NewsFeed,
23 Aug 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim, Mirapex, pramipexole, Parkinson's disease]
Prestwick Pharmaceuticals Appoints George F. Horner III as President and Chief Executive Officer
HSMN NewsFeed,
22 Aug 2006:
Biopharmaceuticals, Personnel[Prestwick Pharmaceuticals]
Teva Announces Health Canada Approves AZILECT(R) (Rasagiline) for Parkinson's Disease
HSMN NewsFeed,
21 Aug 2006:
Biopharmaceuticals, Neurology, Regulatory[Teva Pharmaceutical, AZILECT, rasagiline, Parkinson's disease]
Teva Neuroscience Announces AZILECT(R) Is Now Available in Pharmacies - the First, Once-Daily Treatment for Parkinson's Disease
HSMN NewsFeed,
31 Jul 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, AZILECT, rasagiline, Parkinson's Disease]
Amarin Completes Target Patient Enrollment in European Phase III Trial of Miraxion(TM) in Huntington's Disease
HSMN NewsFeed,
27 Jul 2006:
Biopharmaceuticals, Neurology[Amarin , Miraxion, Huntington's disease]
Stem Cell Authority Ltd.(TM) Offers Ethical Alternative to Alleviate Political Stem Cell Deadlock Between U.S. Congress and President
HSMN NewsFeed,
20 Jul 2006:
Regenerative Medicine[Stem Cell Authority, Wharton's Jelly, stem cell]
SmartPill Wins 510(k) Release from FDA
HSMN NewsFeed,
20 Jul 2006:
Devices, Gastroenterology, FDA[SmartPill Corp, SmartPill]
Stem Cell Therapy International Names Lixian (John) Jiang, Chief Operating Officer, China Division
HSMN NewsFeed,
20 Jul 2006:
Regenerative Medicine, Personnel[Stem Cell Therapy International]
Exelon(R) Patch, the first transdermal therapy for Alzheimer's disease, may provide a promising new approach to treatment
HSMN NewsFeed,
19 Jul 2006:
Biopharmaceuticals, Neurology[Novartis, Exelon, rivastigmine, Alzheimer's disease]
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
HSMN NewsFeed,
18 Jul 2006:
Biopharmaceuticals, Drug Delivery, Neurology[Valeant Pharmaceuticals, Zelapar, selegiline HCI, Parkinson's disease, Zydis]
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
HSMN NewsFeed,
12 Jul 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, Eisai, AZILECT, rasagiline, Parkinson's disease]
Amarin Completes Target Patient Enrollment in North American Phase III Trial of Miraxion(TM) in Huntington's Disease
HSMN NewsFeed,
29 Jun 2006:
Biopharmaceuticals, Neurology[Amarin , Miraxion, Huntington's disease]
Panacea Pharmaceuticals Announces Appointment of Stephen N. Keith, MD, MSPH as President and Chief Operating Officer
HSMN NewsFeed,
28 Jun 2006:
Biopharmaceuticals, Personnel[Panacea Pharmaceuticals]
The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine tartrate) as the First Medication Indicated to Treat Parkinson's Disease Dementia
HSMN NewsFeed,
27 Jun 2006:
Biopharmaceuticals, FDA, Neurology[Novartis, Exelon , rivastigmine, Parkinson's disease, dementia]
Valeant Pharmaceuticals Receives FDA Approval of Zelapar(R) for Patients with Parkinson's Disease
HSMN NewsFeed,
15 Jun 2006:
Biopharmaceuticals, Neurology, FDA[Valeant Pharmaceuticals, Zelapar, selegiline, Parkinson's disease]
ACADIA Pharmaceuticals Announces Appointment of Roger G. Mills, M.D., as Executive Vice President, Development
HSMN NewsFeed,
5 Jun 2006:
Biopharmaceuticals[ACADIA Pharmaceuticals]
Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinson's Disease
HSMN NewsFeed,
25 May 2006:
Biopharmaceuticals, Neurology[Antipodean Pharmaceuticals, MitoQ , mitoquinone, Parkinson's Disease]
FDA Advisory Committee Recommends Approval of Exelon(R) (rivastigmine tartrate) in the Treatment of Dementia Associated with Parkinson's Disease
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Neurology, FDA[Novartis, Exelon, rivastigmine, Parkinson's Disease]
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Neurology, FDA[Teva Pharmaceutical, AZILECT, rasagiline, Parkinson's Disease]
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Neurology, FDA[Teva Pharmaceutical, AZILECT, rasagiline, Parkinson's Disease]
Amarin Acquires Parkinson's Disease Drug Candidate
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Neurology, Acquisitions[Amarin Corp, apomorphine, Parkinson's Disease]
Boston Life Sciences, Inc. Solidifies Comprehensive Axon Regeneration Position with Children's Hospital Boston
HSMN NewsFeed,
11 May 2006:
Biopharmaceuticals, Neurology, Regenerative Medicine[Boston Life Sciences, Axon Regeneration]
Stem Cell Therapeutics Corp. Announces Issuance of Second US Patent
HSMN NewsFeed,
11 May 2006:
Regenerative Medicine[Stem Cell Therapeutics, stem cell]
Avicena Announces Phase III ALS Trial Results
HSMN NewsFeed,
9 May 2006:
Biopharmaceuticals, Neurology[Avicena Group, ALS-02, amyotrophic lateral sclerosis]
VSM reports progress on using MEG for diagnosing Alzheimer's and Parkinson's
HSMN NewsFeed,
8 May 2006:
Devices, Neurology[VSM MedTech, magnetoencephalography, Alzheimer's disease Parkinson's disease]
Questcor Announces the Acquisition of Doral(R) (quazepam)
HSMN NewsFeed,
5 May 2006:
Biopharmaceuticals, Neurology, Acquisitions[Questcor Pharmaceuticals, MedPointe, Doral , quazepam]
World-Renowned Safety Consultant Joy A. Cavagnaro Joins BrainStorm Cell Therapeutics
HSMN NewsFeed,
1 May 2006:
Regenerative Medicine, Personnel[BrainStorm Cell Therapeutics]
AVANIR Announces Neurodex Phase III Trial Results Published in Annals of Neurology
HSMN NewsFeed,
28 Apr 2006:
Biopharmaceuticals, Neurology[AVANIR Pharmaceuticals, Neurodex, IEED, pseudobulbar affect, emotional lability]
Medtronic to Pursue Major Clinical Trial of Deep Brain Stimulation as Depression Treatment
HSMN NewsFeed,
25 Apr 2006:
Devices, Neurosurgery[Medtronic, deep brain stimulation, neurostimulation, Kinetra, Soletra]
Medtronic Announces Clinical Trials Strategy for Neurological and Urological Therapies
HSMN NewsFeed,
24 Apr 2006:
Devices, Urology , Neurology[Medtronic, neurostimulation, needle ablation, Intrathecal baclofen]
Acuity Pharmaceuticals Continues Pipeline Expansion By Licensing a Novel Broad Spectrum Anti-Infective for Ophthalmic Use
HSMN NewsFeed,
20 Apr 2006:
Biopharmaceuticals, Ophthalmology, Licensing[Acuity Pharmaceuticals, Pathogenics, N-chlorotaurine]
Pathogenics, Inc. Licenses Worldwide Rights to Novel Anti-Infective Compound for Ophthalmological Use
HSMN NewsFeed,
19 Apr 2006:
Biopharmaceuticals, Ophthalmology, Licensing[Pathogenics, Acuity Pharmaceuticals, N-Chlorotaurine]
ACADIA Pharmaceuticals Announces Positive Clinical Trial Results Demonstrating That ACP-103 Increases Slow Wave Sleep
HSMN NewsFeed,
19 Apr 2006:
Biopharmaceuticals[ACADIA Pharmaceuticals, ACP-103, Slow Wave Sleep]
Reata Announces Licensing of Novel Class of Anti-Inflammatory Compounds; Drugs Have Broad Potential Across Multiple Therapeutic Areas
HSMN NewsFeed,
17 Apr 2006:
Biopharmaceuticals, Licensing[Reata Pharmaceuticals, tricyclic bis-enones]
Primitive Adult Stem Cells Found in Peripheral Blood
HSMN NewsFeed,
17 Apr 2006:
Regenerative Medicine[Moraga Biotechnology, Blastomere-Like Stem Cells, BLSC, stem cell]
Elekta to Deliver Sophisticated 3-D Brain Mapping Technology to Leading UK Institution
HSMN NewsFeed,
10 Apr 2006:
Devices, Neurology[Elekta, Neuromag , magnetoencephalography]
Pfizer to Expand Neuroscience Research With Acquisition of Biotech Company Rinat Neuroscience
HSMN NewsFeed,
6 Apr 2006:
Biopharmaceuticals, Mergers & Acquisitions[Pfizer, Rinat Neuroscience]
SCHWARZ PHARMA Presents Clinical Data on Rotigotine Transdermal Patch at the Annual Meeting of the American Academy of Neurology
HSMN NewsFeed,
6 Apr 2006:
Biopharmaceuticals, Neurology, Drug Delivery[SCHWARZ PHARMA, Rotigotine, Parkinson's Disease, transdermal patch]
Solstice Neurosciences, Inc. Releases New Data Confirming Effectiveness of Myobloc as a First-Line Therapy
HSMN NewsFeed,
5 Apr 2006:
Biopharmaceuticals, Neurology[Solstice Neurosciences, MYOBLOC, Botulinum Toxin Type B, Cervical Dystonia]
Pramipexole Significantly Improved Symptoms of Restless Legs Syndrome, New Studies Show
HSMN NewsFeed,
5 Apr 2006:
Biopharmaceuticals, Neurology[Boehringer Ingelheim Pharmaceuticals, Restless Legs Syndrome, pramipexole]
Life Science Angels Invests in NeuroHealing Pharmaceuticals
HSMN NewsFeed,
5 Apr 2006:
Biopharmaceuticals, Venture Capital[Life Science Angels, NeuroHealing Pharmaceuticals]
AVANIR's Neurodex NDA Accepted with Priority Review for Involuntary Emotional Expression Disorder
HSMN NewsFeed,
4 Apr 2006:
Biopharmaceuticals, Neurology, FDA[AVANIR Pharmaceuticals, Neurodex, IEED, pseudobulbar affect]
Neurology Academy Upgrades Deep Brain Stimulation in Latest Parkinson's Treatment Guidelines
HSMN NewsFeed,
3 Apr 2006:
Devices, Neurology[Medtronic, Parkinson's disease, deep brain stimulation]
Prestwick Pharmaceuticals Receives FDA Approvable Letter for XENAZINE(R) (Tetrabenazine) for Treatment of Chorea Associated with Huntington's Disease
HSMN NewsFeed,
31 Mar 2006:
Biopharmaceuticals, Neurology, FDA[Prestwick Pharmaceuticals, XENAZINE, tetrabenazine, Huntington's disease]
Avicena Compound Receives Orphan Drug Designation for Huntington's Disease
HSMN NewsFeed,
22 Mar 2006:
Biopharmaceuticals, Neurology, FDA[Avicena Group, HD-02, Huntington's disease]
Boston Life Sciences Ends ALTROPANE(R) POET-1 Phase III Trial Early to Evaluate Full Data Set
HSMN NewsFeed,
20 Mar 2006:
Biopharmaceuticals, Neurology[Boston Life Sciences, POET-1, ALTROPANE]
Avicena Announces Promising Phase II Results From Parkinson's Disease Trial
HSMN NewsFeed,
14 Mar 2006:
Biopharmaceuticals, Neurology[Avicena, PD-02, Parkinson's disease]
Neurocrine Biosciences Announces Results of The Phase II Study in Multiple Sclerosis
HSMN NewsFeed,
8 Mar 2006:
Biopharmaceuticals, Neurology[Neurocrine Biosciences]
Kyowa Releases Results to Phase III Clinical Studies of an Anti-Parkinson's Disease Drug Istradefylline (KW-6002) Conducted Overseas
HSMN NewsFeed,
7 Mar 2006:
Biopharmaceuticals, Neurology[Kyowa, KW-6002, Istradefyllin, Parkinson's Disease]
Xyrem(R) (Sodium Oxybate) Now Available for the Treatment of Excessive Daytime Sleepiness (EDS) in Patients With Narcolepsy
HSMN NewsFeed,
6 Mar 2006:
Biopharmaceuticals, FDA[Jazz Pharmaceuticals, Xyrem, narcolepsy]
Stem Cell Therapy International Reports Successful Treatment of Multiple Sclerosis Patient With Stem Cell Transplantation Therapy
HSMN NewsFeed,
27 Feb 2006:
Regenerative Medicine, Neurology[Stem Cell Therapy International, multiple sclerosis, stem cell]
Valeant Pharmaceuticals Receives FDA Approval of Less-Restrictive Labeling for Tasmar(R)
HSMN NewsFeed,
22 Feb 2006:
Biopharmaceuticals, Neurology, FDA[Valeant Pharmaceuticals, Tasmar, tolcapone, Parkinson's disease]
Study Published in Neurology Shows Tetrabenazine Significantly Improves Debilitating Movement Disorder Caused by Huntington's Disease
HSMN NewsFeed,
14 Feb 2006:
Biopharmaceuticals, Neurology[Prestwick Pharmaceuticals, tetrabenazine, Huntington's Disease, chorea]
Altea Therapeutics and Teikoku Seiyaku Co. Ltd. Enter into an Agreement for the Development, Manufacture, and Commercialization in Japan of a New Transdermal Therapy for Parkinson's Disease
HSMN NewsFeed,
1 Feb 2006:
Biopharmaceuticals, Neurology, Drug Delivery, Licensing[Altea Therapeutics, Teikoku Seiyaku, Parkinson's Disease]
Neurologix Announces Appointment of Marc Panoff as Chief Financial Officer
HSMN NewsFeed,
25 Jan 2006:
Biopharmaceuticals, Personnel[Neurologix]
ACADIA Pharmaceuticals Announces Additional $10 Million Equity Investment by Sepracor
HSMN NewsFeed,
17 Jan 2006:
Biopharmaceuticals[ACADIA Pharmaceuticals, Sepracor]
ACADIA Pharmaceuticals Announces Appointment of David C. Furlano, Ph.D., as Vice President, Regulatory Affairs
HSMN NewsFeed,
9 Jan 2006:
Biopharmaceuticals, Personnel[ACADIA Pharmaceuticals]
Boston Life Sciences, Inc. Announces Appointment of Senior Vice President, Regulatory Affairs and Quality
HSMN NewsFeed,
5 Jan 2006:
Biopharmaceuticals, Personnel[Boston Life Sciences]
Genzyme Acquires Avigen's Gene Therapy Technology
HSMN NewsFeed,
21 Dec 2005:
Biopharmaceuticals, Acquisitions[Genzyme, Avigen , Gene Therapy]
Titan Announces Favorable Results of Pilot Clinical Study of Spheramine(R) Reported in Archives of Neurology
HSMN NewsFeed,
15 Dec 2005:
Biopharmaceuticals, Neurology[Titan Pharmaceuticals, Schering, Parkinson's disease, Spheramine]
Stem Cell Therapy International Names Fred J. Villella as Business Advisor for Governmental Affairs
HSMN NewsFeed,
12 Dec 2005:
Biopharmaceuticals, Regenerative Medicine, Personnel[Stem Cell Therapy International]
Pramipexole Delivered Sustained Efficacy in a Large Clinical Trial of Patients With Restless Legs Syndrome
HSMN NewsFeed,
9 Dec 2005:
Biopharmaceuticals[Boehringer Ingelheim, pramipexole, Restless Legs Syndrome]
New Data Suggest Pramipexole Relieves Symptoms of Restless Legs Syndrome (RLS) and Is Well-Tolerated
HSMN NewsFeed,
9 Dec 2005:
Biopharmaceuticals[Boehringer Ingelheim, Restless Legs Syndrome, pramipexole]
Cephalon, Inc. Announces Agreement to Acquire Zeneus Holdings Limited
HSMN NewsFeed,
6 Dec 2005:
Biopharmaceuticals, Mergers & Acquisitions[Cephalon, Zeneus Holdings, Zeneus Pharma]
Xyrem(R) (Sodium Oxybate) Receives FDA Approval for the Treatment of Excessive Daytime Sleepiness in Patients With Narcolepsy
HSMN NewsFeed,
22 Nov 2005:
Biopharmaceuticals, FDA[Jazz Pharmaceuticals, Xyrem, sodium oxybate, narcolepsy]
Cita NeuroPharmaceuticals Inc. Accepts Offer by UK-Based Vernalis plc
HSMN NewsFeed,
18 Nov 2005:
Biopharmaceuticals, Mergers & Acquisitions[Cita NeuroPharmaceuticals, Vernalis]
Vernalis plc Announces Proposed Acquisition of Cita NeuroPharmaceuticals Inc.
HSMN NewsFeed,
18 Nov 2005:
Biopharmaceuticals, Mergers & Acquisitions[Vernalis, Cita NeuroPharmaceuticals]
Biogen Idec Finds That Nogo Receptor Could Play a Role in the Progression of Parkinson's Disease
HSMN NewsFeed,
17 Nov 2005:
Biopharmaceuticals, Regenerative Medicine, Neurology[Biogen Idec, Nogo Receptor, Neuroprotection, Parkinson's Disease]
Predix Pharmaceuticals Announces Positive Findings from First Clinical Trial in Alzheimer's Disease Patients
HSMN NewsFeed,
14 Nov 2005:
Biopharmaceuticals, Neurology[Predix Pharmaceuticals, PRX-03140, Alzheimer's Disease]
ACADIA Pharmaceuticals Announces Initial Results From Ongoing Single-Dose Clinical Trial of ACP-104 in Schizophrenia Patients
HSMN NewsFeed,
10 Nov 2005:
Biopharmaceuticals[ACADIA Pharmaceuticals, ACP-104, schizophrenia]
Memory Pharmaceuticals Commences Phase 2a Trial of MEM 1003 in Alzheimer's Disease
HSMN NewsFeed,
4 Nov 2005:
Biopharmaceuticals, Neurology[Memory Pharmaceuticals, MEM 1003, Alzheimer's disease]
Mylan Announces the Sale of Apokyn to Vernalis
HSMN NewsFeed,
4 Nov 2005:
Biopharmaceuticals, Acquisitions[Mylan Laboratories, Vernalis, Mylan Bertek, Apokyn, apomorphine]
Stem Cell Therapy International Announces the Successful Treatment of Stroke Victim Who Received Stem Cell Transplantation Therapy
HSMN NewsFeed,
27 Oct 2005:
Biopharmaceuticals, Neurology, Regenerative Medicine[Stem Cell Therapy International, stem cell, stroke]
Stem Cell Therapy International Names Dr. Alexey Bersenev, MD., PhD. to Its U.S. Medical and Scientific Advisory Board
HSMN NewsFeed,
24 Oct 2005:
Biopharmaceuticals, Regenerative Medicine, Personnel[Stem Cell Therapy International]
Stem Cell Therapy International Names Tulane University Stem Cell Expert to Its Medical and Scientific Advisory Board
HSMN NewsFeed,
21 Oct 2005:
Biopharmaceuticals, Regenerative Medicine, Personnel[Stem Cell Therapy International, Weiwen Deng, stem cell]
Protection of Normal Tissue from Radiation-Induced Injury Using AEOL 10150 Presented at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology
HSMN NewsFeed,
18 Oct 2005:
Biopharmaceuticals, Oncology[Aeolus Pharmaceuticals]
St. Jude Medical and Advanced Neuromodulation Systems Announce Definitive Agreement
HSMN NewsFeed,
16 Oct 2005:
Devices, Neurology, Mergers & Acquisitions[St. Jude Medical, Advanced Neuromodulation Systems]
Study Shows Applied NeuroSolutions' Test Improves Early Detection and Accurate Diagnosis of Alzheimer's Disease
HSMN NewsFeed,
12 Oct 2005:
Diagnostics, Neurology[Applied NeuroSolutions, Alzheimer's disease, p-tau 231]
Boston Life Sciences, Inc. Announces Appointment of Chief Medical Officer
HSMN NewsFeed,
5 Oct 2005:
Biopharmaceuticals, Personnel[Boston Life Sciences]
MGI PHARMA Completes Acquisition of Guilford Pharmaceuticals
HSMN NewsFeed,
3 Oct 2005:
Biopharmaceuticals, Mergers & Acquisitions[MGI PHARMA, Guilford Pharmaceuticals]
Barr Confirms Patent Challenge of Mirapex(R)
HSMN NewsFeed,
28 Sep 2005:
Biopharmaceuticals, Generics[Barr Pharmaceuticals, Pramipexole, Boehringer Ingelheim, Mirapex]
Stem Cell Therapy International Names Four Leading Scientists to Scientific Advisory Board
HSMN NewsFeed,
28 Sep 2005:
Regenerative Medicine, Personnel[Stem Cell Therapy International, stem cell]
FoldRx Pharmaceuticals, Inc. Appoints Christoph M. Adams, Ph.D., as Chief Business Officer
HSMN NewsFeed,
26 Sep 2005:
Biopharmaceuticals, Personnel[FoldRx Pharmaceuticals]
Neurologix Announces Positive Interim Results of Landmark Gene Therapy Clinical Trial for Patients with Parkinson's Disease
HSMN NewsFeed,
26 Sep 2005:
Biopharmaceuticals, Neurology[Neurologix, glutamic acid decarboxylase, Gene Therapy, Parkinson's Disease]
Medtronic Names Dr. Richard Kuntz Senior Vice President and President of Neurological Businesses
HSMN NewsFeed,
21 Sep 2005:
Devices, Neurology, Personnel[Medtronic]
Ceregene Reports Initiation of Phase 1 Clinical Trial of Novel Gene Therapy for Patients With Parkinson's Disease
HSMN NewsFeed,
21 Sep 2005:
Biopharmaceuticals, Neurology[Ceregene, CERE-120, Parkinson's disease, gene therapy]
First Clinical Guidelines for Diagnosing and Treating Normal Pressure Hydrocephalus (NPH) Established
HSMN NewsFeed,
20 Sep 2005:
Devices, Neurosurgery[Codman, normal pressure hydrocephalus]
Stem Cell Therapy International Signs Exclusive License Agreement for the Supply of Stem Cells and Use of 26 Related Patents from the Institute of Cell Therapy In Kiev, Ukraine
HSMN NewsFeed,
19 Sep 2005:
Regenerative Medicine, Licensing[Stem Cell Therapy International, Institute of Cell Therapy, stem cell]
Stem Cell Therapy International Corp. is Acquired by Altadyne
HSMN NewsFeed,
16 Sep 2005:
Regenerative Medicine, Mergers & Acquisitions[Stem Cell Therapy International, Altadyne]
Aeolus Pharmaceuticals, Inc. Announces Relocation of Headquarters and Operations to Southern California
HSMN NewsFeed,
1 Sep 2005:
Biopharmaceuticals[Aeolus Pharmaceuticals]
Medtronic Acquires Image-Guided Neurologics
HSMN NewsFeed,
30 Aug 2005:
Devices, Neurosurgery, Mergers & Acquisitions[Medtronic, Image-Guided Neurologics, stereotactic]
Blood Flow to Brain May Be Clue to Certain Dementias
HSMN NewsFeed,
30 Aug 2005:
Devices, Neurology, Radiology[RSNA, cerebral blood flow, dementia, Alzheimer's disease]
Memory Pharmaceuticals Amends PDE4 Collaboration with Roche
HSMN NewsFeed,
18 Aug 2005:
Biopharmaceuticals, Neurology, Licensing[Memory Pharmaceuticals, Roche, PDE4, Alzheimer's disease]
Amarin Announces Appointment of Dr. Anthony Clarke as Vice President Clinical Development
HSMN NewsFeed,
16 Aug 2005:
Biopharmaceuticals, Personnel[Amarin Corporation, Amarin Neuroscience]
Boston Life Sciences and the FDA Reach Agreement on a New SPA for the Pivotal Phase III Program for ALTROPANE(R) Molecular Imaging Agent
HSMN NewsFeed,
15 Aug 2005:
Biopharmaceuticals, Radiology, Neurology, FDA[Boston Life Sciences, ALTROPANE, contrast agent, POET-1, POET-2]
Latest-generation Leksell Gamma Knife(R) Offers Enhanced Treatment Options for Brain Tumors and Disorders
HSMN NewsFeed,
15 Aug 2005:
Devices, Oncology, Neurosurgery[Elekta, Gamma Knife, radiosurgery]
Teva Receives Follow-up Approvable Letter from FDA Regarding Agilect(R)
HSMN NewsFeed,
5 Aug 2005:
Biopharmaceuticals, Neurology, FDA[Teva Pharmaceutical, AGILECT, rasagiline, Parkinson's disease]
Neose Technologies Announces Restructuring Of Operations; Provides Update On Corporate Objectives
HSMN NewsFeed,
4 Aug 2005:
Biopharmaceuticals[Neose Technologies, GlycoPEGylation, GlycoAdvance]
Boston Life Sciences Takes Steps to Further Its Focus On Neurology
HSMN NewsFeed,
26 Jul 2005:
Biopharmaceuticals, Neurology[Boston Life Sciences, FluoroPharma, imaging agent]
Newron Pharmaceuticals Completes Enrollment in Safinamide Phase III Pivotal Clinical Trial for Parkinson's Disease
HSMN NewsFeed,
21 Jul 2005:
Biopharmaceuticals, Neurology[Newron Pharmaceuticals, Safinamide, Parkinson's disease]
StemCells, Inc. Grants License to ReNeuron, Receives Stake in UK Stem Cell Company
HSMN NewsFeed,
6 Jul 2005:
Biopharmaceuticals, Regenerative Medicine, Licensing[StemCells, ReNeuron]
Power3 Announces Results of Studies Measuring Levels of Protein Biomarkers from Blood Serum to Diagnose Neurological Disorders
HSMN NewsFeed,
5 Jul 2005:
Diagnostics, Neurology[Power3 Medical Products]
AVANIR Submits NDA for Neurodex(TM)
HSMN NewsFeed,
30 Jun 2005:
Biopharmaceuticals, Neurology, FDA[AVANIR Pharmaceuticals, Neurodex, pseudobulbar affect, emotional incontinence]
Medtronic Launches New Online Resource for Essential Tremor
HSMN NewsFeed,
27 Jun 2005:
Devices[Medtronic, Activa , essential tremor]
Teva and Lundbeck Announce That Azilect (Rasagiline) for Parkinson's Disease is Now Available in the United Kingdom
HSMN NewsFeed,
27 Jun 2005:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, Lundbeck, Azilect, Parkinson's disease]
Breakthrough Study at Children's Hospital of Pittsburgh Finds Adult Stem Cells Show Same Ability to Self-Renew as Embryonic
HSMN NewsFeed,
23 Jun 2005:
Regenerative Medicine[stem cell, embryonic stem cell]
Geron Provides Update on Human Embryonic Stem Cell Programs at International Society for Stem Cell Research Annual Meeting
HSMN NewsFeed,
23 Jun 2005:
Biopharmaceuticals, Regenerative Medicine[Geron Corporation, embryonic stem cell]
Advanced Neuromodulation Systems Announces Expanded Market Launch of Its Eon(TM) Rechargeable Neurostimulation System
HSMN NewsFeed,
21 Jun 2005:
Devices, Neurology[Advanced Neuromodulation Systems, Neurostimulation]
Fabre-Kramer Re-Acquires Gepirone ER Rights From Organon
HSMN NewsFeed,
15 Jun 2005:
Biopharmaceuticals[Fabre-Kramer Pharmaceuticals, Organon, Akzo Nobel, Gepirone]
Intra-Cellular Therapies, Inc. Receives Exclusive License for Central Nervous System Compounds from Bristol-Myers Squibb Company
HSMN NewsFeed,
1 Jun 2005:
Biopharmaceuticals, Licensing[Intra-Cellular Therapies, Bristol-Myers Squibb]
Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate Strategy
HSMN NewsFeed,
24 May 2005:
Biopharmaceuticals[Guilford Pharmaceuticals]
Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCO
HSMN NewsFeed,
18 May 2005:
Biopharmaceuticals, Neurology, Oncology[Guilford Pharmaceuticals, NAALADase]
Neurologix Licenses Promising New Gene for Treatment of Alzheimer's and Other CNS Disorders
HSMN NewsFeed,
18 May 2005:
Biopharmaceuticals, Neurology, Licensing[Neurologix, Alzheimer's disease]
Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant Glioma
HSMN NewsFeed,
17 May 2005:
Biopharmaceuticals, Oncology[Guilford Pharmaceuticals, GLIADEL Wafer, malignant glioma]
Cephalon and H. Lundbeck Announce Discontinuation of CEP-1347 Clinical Trial in Parkinson's Disease
HSMN NewsFeed,
11 May 2005:
Biopharmaceuticals, Neurology[Cephalon, H. Lundbeck, CEP-1347, Parkinson's disease]
Power3 Medical Submits Pre-IDE Application for NuroPro(TM) Blood Tests to Diagnose Neuromuscular Disorders
HSMN NewsFeed,
11 May 2005:
Diagnostics, FDA[Power3 Medical Products, NuroPro]
Memory Pharmaceuticals Appoints Tony Scullion as Executive Chairman and James R. Sulat as President and CEO
HSMN NewsFeed,
10 May 2005:
Biopharmaceuticals, Personnel[Memory Pharmaceuticals]
Newron Pharmaceuticals Completes Management Team with Appointment of Chief Financial Officer and Chief Medical Officer
HSMN NewsFeed,
4 May 2005:
Biopharmaceuticals, Personnel[Newron Pharmaceuticals]
Neurologix and Medtronic Agree to Develop Gene Therapy Infusion Catheters
HSMN NewsFeed,
2 May 2005:
Devices, Neurology[Neurologix, Medtronic, gene therapy, Parkinson's disease, epilepsy]
ACADIA Pharmaceuticals Announces Election of Mary Ann Gray, Ph.D. to Board of Directors
HSMN NewsFeed,
28 Apr 2005:
Biopharmaceuticals, Personnel[ACADIA Pharmaceuticals]
Ceregene Scientific Co-Founder Publishes Alzheimer's Disease Clinical Trial Results in Nature Medicine
HSMN NewsFeed,
25 Apr 2005:
Biopharmaceuticals, Neurology[Ceregene, Alzheimer's disease, gene therapy, nerve growth factor, CERE-110]
Update of Neurologix Phase I Clinical Trial of Gene Therapy for Parkinson's Disease Presented at AANS Annual Meeting
HSMN NewsFeed,
22 Apr 2005:
Biopharmaceuticals, Neurosurgery, Neurology[Neurologix, gene therapy, Parkinson's disease]
MAP Pharmaceuticals Appoints Timothy S. Nelson as President and Chief Executive Officer
HSMN NewsFeed,
18 Apr 2005:
Biopharmaceuticals, Personnel[MAP Pharmaceuticals]
New Data Reported on Tetrabenazine for the Treatment of Pediatric Hyperkinetic Movement Disorders
HSMN NewsFeed,
15 Apr 2005:
Biopharmaceuticals, Neurology[Prestwick Pharmaceuticals, tetrabenazine, XENAZINE, NITOMAN]
Advanced Neuromodulation Systems Announces IDE Approval to Investigate Libra(TM) DBS System for Parkinson's Disease
HSMN NewsFeed,
15 Apr 2005:
Devices, Neurology, FDA[Advanced Neuromodulation Systems, Libra , Deep Brain Stimulation]
GB Therapeutics changes its name to Cita NeuroPharmaceuticals Inc.
HSMN NewsFeed,
14 Apr 2005:
Biopharmaceuticals[GB Therapeutics, Cita NeuroPharmaceuticals]
Additional items found: The Network Archive contains
177 additional itemsParkinson\'s Disease
Public
Feeds 
Full text >>